Centre For Local Research into Public Space (CELOS)
Show search options
You are on the [Vaccines 2021] page of folder [Background Research]
For the cover page of this folder go to the Vaccines
March 5, 2022
From Pfizer: CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021 read more
Nov.2, 2021
BMJ: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Oct.27, 2021 (updated from Sept.10, 2021)
European Journal of Epidemiology: Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
Sep.24, 2021
Wall Street Journal, Drug Makers Bet on Covid19 Treatments
Excerpt: Covid-19 isn’t likely to disappear any time soon, even as the public-health emergency abates. As a result, antiviral drugs under development might be the pharmaceutical industry’s next big opportunity.....[F]rom a financial perspective, these drug companies already have large top lines; Pfizer, Merck and Roche combined for about $150 billion in revenue last year.
Still, fresh growth opportunities for large drugmakers are typically in short supply. The substantial Covid-19 testing apparatus makes a prompt diagnosis and effective use of such medication more realistic than a typical flu case. And governments around the world would likely be willing to buy a lot of medication to help prevent the severe economic consequences that Covid-19 outbreaks and lockdown policies have caused.
Investors should be willing to swallow this pill without much hesitation.
Sept.22, 2021
The Guardian, Spirited Away: How the counterculture fell prey to the far-right’s conspiracy theories.
Excerpt: There has long been an overlap between certain new age and far-right ideas. The Nazis embraced astrology, pagan festivals, organic farming, forest conservation, ecological education and nature worship. They promoted homeopathy and “natural healing”, and tended to resist vaccination. We should be aware of this history...
August 17, 2021
Wall Street Journal "Follow Your Nose to Herd Immunity"
Excerpt: The mucous membranes secrete a particular form of antibodies of the Immunoglobulin A type, or IgA. But vaccines injected into our muscles—including all the approved inoculations against Covid—are largely ineffective at stimulating the secretion of IgA into our noses that occurs after actual infection with a virus. As a result, vaccinated people can contract a Covid-19 infection confined to the mucous membranes....[W]e shouldn’t shun people who have recovered from Covid. Vaccine mandates for in-person interactions—whether imposed by governments, employers or businesses—should make exceptions for the previously infected, who thanks to natural mucosal immunity are likely at less risk than never- infected vaccinated people of spreading the virus to others.
August 8, 2021
British Medical Journal Transparency in covid vaccine research
June 11, 2021
Heart disease possibly related to the Pfizer Vaccine: detailed UK report
May 12, 2021
May 12, 2021
CDC data in a piece by Larry Solomon
May 11, 2021
April 20, 2021
The Lancet: Covid vaccine efficacy and effectiveness: The elephant (not) in the room
Vaccine efficacy is generally reported as a relative risk reduction (RRR). It uses the relative risk (RR)—ie, the ratio of attack rates with and without a vaccine—which is expressed as 1–RR. Ranking by reported efficacy gives relative risk reductions of 95% for the Pfizer–BioNTech, 94% for the Moderna–NIH, 90% for the Gamaleya, 67% for the J&J, and 67% for the AstraZeneca–Oxford vaccines. However, RRR should be seen against the background risk of being infected and becoming ill with COVID-19, which varies between populations and over time. Although the RRR considers only participants who could benefit from the vaccine, the absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs: 1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines.
April 19, 2021
TORONTO — Today, Dr. David Williams, Ontario's Chief Medical Officer of Health, issued the following statement to expand COVID-19 vaccination eligibility at pharmacies and primary care settings to individuals aged 40 and over. link